These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28888039)

  • 1. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
    Chen MF; Chen PT; Lu MS; Chen WC
    Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
    Tsai MS; Chen WC; Lai CH; Chen YY; Chen MF
    Oral Oncol; 2017 Oct; 73():88-96. PubMed ID: 28939082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
    Ji Y; Li X; Li Y; Zhong Y; Cao J; Xu R; Wang J; Zhou F; Li X; Yu D; Wen JG; Goscinski MA; Zhang M; Nesland JM; Suo Z
    Anticancer Res; 2016 Jan; 36(1):343-9. PubMed ID: 26722063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
    Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
    Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A
    Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma.
    Ota N; Ohno J; Seno K; Taniguchi K; Ozeki S
    Int J Oncol; 2014 Feb; 44(2):435-42. PubMed ID: 24285422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
    Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z
    Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
    Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
    Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
    Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
    Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of COX-2 expression in human esophageal squamous cell carcinoma.
    Zhi H; Wang L; Zhang J; Zhou C; Ding F; Luo A; Wu M; Zhan Q; Liu Z
    Carcinogenesis; 2006 Jun; 27(6):1214-21. PubMed ID: 16352617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
    Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
    Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
    Zhou C; Sun B
    Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
    Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
    Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.